The monocyte monolayer assay, an in vitro method for prediction of in vivo survival of transfused incompatible red blood cells: a review

1. Archer GT. Erythrophagocytosis. Mod Med Aust 1964;7:55. Archer GT. Erythrophagocytosis . Mod Med Aust 1964 ; 7 : 55 . Search in Google Scholar

2. Archer GT. Phagocytosis by human monocytes of red cells coated with antibodies. Vox Sang 1965;10:590–8. Archer GT. Phagocytosis by human monocytes of red cells coated with antibodies . Vox Sang 1965 ; 10 : 590 – 8 . Search in Google Scholar

3. Cline MJ, Lehrer RI. Phagocytosis by human monocytes. Blood 1968;32:423. Cline MJ , Lehrer RI. Phagocytosis by human monocytes . Blood 1968 ; 32 : 423 . Search in Google Scholar

4. Stevens JO, Schanfield MS, Braley JF. Detection of clinically signifcant IgG antibodies by an in vitro human peritoneal macrophage phagocytosis assay (abstract). Transfusion 1976;16:523. Stevens JO Schanfield MS Braley JF. Detection of clinically significant IgG antibodies by an in vitro human peritoneal macrophage phagocytosis assay (abstract) . Transfusion 1976 ; 16 : 523 . Search in Google Scholar

5. Schanfeld MS, Bauman D, Stevens JO. The detection of clinically signifcant “low avidity” erythrocyte alloantibodies by human macrophage assay. Transfusion 1978;10:382. Schanfield MS Bauman D Stevens JO. The detection of clinically significant “low avidity” erythrocyte alloantibodies by human macrophage assay . Transfusion 1978 ; 10 : 382 . Search in Google Scholar

6. Schanfeld MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically signifcant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfeld MS, Eds. Immunobiology of the erythrocyte. New York: Alan Liss, 1980:305–23. Schanfield MS Schoeppner SL Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory . In: Sandler SG Nusbacher J Schanfield MS Eds. Immunobiology of the erythrocyte . New York : Alan Liss , 1980 : 305 – 23 . Search in Google Scholar

7. Hunt JS, Beck ML, Hardman JT, Tegtmeier GE, Bayer WI. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 198 0;74:259 –6 4. Hunt JS Beck ML Hardman JT Tegtmeier GE Bayer WI. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction . Am J Clin Pathol 1980 ; 74 : 259 – 64 . Search in Google Scholar

8. Hunt JS, Beck ML, Wood GW. Monocyte-mediated erythrocyte destruction: a comparative study of current methods. Transfusion 1981;21:735–8. Hunt JS Beck ML Wood GW. Monocyte-mediated erythrocyte destruction: a comparative study of current methods . Transfusion 1981 ; 21 : 735 – 8 . Search in Google Scholar

9. Schanfeld MS, Stevens JO, Bauman D. The detection of clinically signifcant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6. Schanfield MS Stevens JO Bauman D. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay . Transfusion 1981 ; 21 : 571 – 6 . Search in Google Scholar

10. Schoeppner-Esty S, Wahl T, Zawisza J, Mallory D, Davey R. Stimulation of antibody following transfusion of red cells during ⁵¹chromium survival studies. Blood 1986;68:302a. Schoeppner-Esty S Wahl T Zawisza J Mallory D Davey R. Stimulation of antibody following transfusion of red cells during 51chromium survival studies . Blood 1986 ; 68 : 302a . Search in Google Scholar

11. Schoeppner-Esty S, Chin J, Mallory D, Davey R. A comparison of the monocyte monolayer (MMA) to the ⁵¹chromium red cell survival for determining the clinical signifcance of red cell alloantibodies. Blood 1986;68:302a. Schoeppner-Esty S Chin J Mallory D Davey R. A comparison of the monocyte monolayer (MMA) to the 51chromium red cell survival for determining the clinical significance of red cell alloantibodies . Blood 1986 ; 68 : 302a . Search in Google Scholar

12. Eckrich RJ, Mallory DM, Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yt^a. Immunohematology 1995;11: 81–4. Eckrich RJ Mallory DM Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta . Immunohematology 1995 ; 11 : 81 – 4 . Search in Google Scholar

13. Byrne PC, Eckrich RJ, Malamut DC, Mallory DM, Sandler SG. Use of the monocyte monolayer assay (MMA) to predict the clinical signifcance of anti-Cr^a (abstract). Transfusion 1995;35:61S. Byrne PC Eckrich RJ Malamut DC Mallory DM Sandler SG. Use of the monocyte monolayer assay (MMA) to predict the clinical significance of anti-Cra (abstract) . Transfusion 1995 ; 35 : 61S . Search in Google Scholar

14. Garratty G. Predicting the clinical signifcance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, Eds. Clinical and serologic aspects of transfusion reactions. Arlington, VA: AABB, 1982:91–119. Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells . In: Judd WJ Barnes A Eds. Clinical and serologic aspects of transfusion reactions . Arlington, VA : AABB , 1982 : 91 – 119 . Search in Google Scholar

15. Garratty G, Nance S, O’Neill P. Correlation of monocyte monolayer assays and RBC survival in patients with allo-antibodies of questionable clinical signifcance. Transfusion 198 5;2 5:474. Garratty G Nance S O’Neill P. Correlation of monocyte monolayer assays and RBC survival in patients with alloantibodies of questionable clinical significance . Transfusion 1985 ; 25 : 474 . Search in Google Scholar

16. Garratty G, Nance S, O’Neill P. Factors that afect interpretation of monocyte monolayer assays. Transfusion 1986;26:570. Garratty G Nance S O’Neill P. Factors that affect interpretation of monocyte monolayer assays . Transfusion 1986 ; 26 : 570 . Search in Google Scholar

17. Nance S, Arndt P, Garratty G. Predicting the signifcance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:4 49–52. Nance S Arndt P Garratty G. Predicting the significance of red cell alloantibodies using a monocyte monolayer assay . Transfusion 1987 ; 27 : 449 – 52 . Search in Google Scholar

18. Nance SJ, Arndt PA, Garratty G. The efect of fresh serum on monocyte monolayer reactivity. Transfusion 1988;28:398–9. Nance SJ Arndt PA Garratty G. The effect of fresh serum on monocyte monolayer reactivity . Transfusion 1988 ; 28 : 398 – 9 . Search in Google Scholar

19. Levy GJ, Selset G, McQuiston D, et al. Clinical signifcance of anti-Yt^b: report of a case using a ⁵¹chromium red cell survival study. Transfusion 1988;28:265–7. Levy GJ Selset G McQuiston D Clinical significance of anti-Ytb: report of a case using a 51chromium red cell survival study . Transfusion 1988 ; 28 : 265 – 7 . Search in Google Scholar

20. Garratty G. Predicting the clinical signifcance of red cell antibodies with in vitro cellular assays. Trans Med Rev 1990;4:297–312. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays . Trans Med Rev 1990 ; 4 : 297 – 312 . Search in Google Scholar

21. Nance S. Review: measuring red cell survival and determining the clinical signifcance of red cell antibodies. Immunohematology 1995;11:31–8. Nance S. Review: measuring red cell survival and determining the clinical significance of red cell antibodies . Immunohematology 1995 ; 11 : 31 – 8 . Search in Google Scholar

22. Lucas GF, Hadley SG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993;33:484–7. Lucas GF Hadley SG Nance SJ Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test . Transfusion 1993 ; 33 : 484 – 7 . Search in Google Scholar

23. Nance S, Nelson J, O’Neill P, Garratty G. Correlation of monocyte monolayer assays, maternal antibody titers, and clinical course in hemolytic disease of the newborn (HDN) (abstract). Transfusion 1984;24:415. Nance S Nelson J O’Neill P Garratty G. Correlation of monocyte monolayer assays, maternal antibody titers, and clinical course in hemolytic disease of the newborn (HDN) (abstract) . Transfusion 1984 ; 24 : 415 . Search in Google Scholar

24. Nance S, Nelson J, Horenstein J, O’Neill P, Garratty G. Predictive value of amniocentesis versus monocyte monolayer assays in pregnant women with Rh antibodies (abstract). Transfusion 1986;26:570. Nance S Nelson J Horenstein J O’Neill P Garratty G. Predictive value of amniocentesis versus monocyte monolayer assays in pregnant women with Rh antibodies (abstract) . Transfusion 1986 ; 26 : 570 . Search in Google Scholar

25. Nance SJ, Nelson JM, Horenstein J, Amdt PA, Platt LD, Garratty G. Monocyte monolayer assay: an efcient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989;92:89–92. Nance SJ Nelson JM Horenstein J Amdt PA Platt LD Garratty G. Monocyte monolayer assay: an efficient non- invasive technique for predicting the severity of hemolytic disease of the newborn . Am J Clin Pathol 1989 ; 92 : 89 – 92 . Search in Google Scholar

26. Mollison PL. Results of tests with diferent cellular bioassays in relation to severity of RhD haemolytic disease: report from nine collaborating laboratories. Vox Sang 1991;60:225–9. Mollison PL. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease: report from nine collaborating laboratories . Vox Sang 1991 ; 60 : 225 – 9 . Search in Google Scholar

27. Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991;77:221–8. Hadley AG Kumpel BM Leader KA Poole GD Fraser ID. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn . Br J Haematol 1991 ; 77 : 221 – 8 . Search in Google Scholar

28. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical signifcance of blood group alloantibodies. Transfusion 2004;44:1273–81. Arndt PA Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies . Transfusion 2004 ; 44 : 1273 – 81 . Search in Google Scholar

29. Nance SJ, Arndt P. What to do when all RBCs are incompatible: serological aspects. Immunohematology 2004;3:147–60. Nance SJ Arndt P. What to do when all RBCs are incompatible: serological aspects . Immunohematology 2004 ; 3 : 147 – 60 . Search in Google Scholar

30. Church A, Mallory D, Kavitsky D, Nance S. Impact of complement in the monocyte monolayer assay (abstract). Transfusion 1997;37(Suppl):27S. Church A Mallory D Kavitsky D Nance S. Impact of complement in the monocyte monolayer assay (abstract) . Transfusion 1997 ; 37 ( Suppl ): 27S . Search in Google Scholar

31. Maurer J, Kavitsky DM, Meny G, Nance S. Monocyte monolayer assay (MMA) to predict clinical signifcance of RBC alloantibodies: an update. Transfusion 2011;51(Suppl):171A. Maurer J Kavitsky DM Meny G Nance S. Monocyte monolayer assay (MMA) to predict clinical significance of RBC alloantibodies: an update . Transfusion 2011 ; 51 ( Suppl ): 171A . Search in Google Scholar

32. Keller MA, Nickle P, Mansfeld P, et al. Use of monocyte monolayer assay in a patient with anti-hr^S and -Hr. Transfusion 2017;57(S 3) : 3 6 A. Keller MA Nickle P Mansfield P Use of monocyte monolayer assay in a patient with anti-hrS and -Hr. Transfusion 2017 ; 57 ( S3 ): 36A . Search in Google Scholar

33. Nance S. A review of the in vitro methods to predict the clinical signifcance of red cell alloantibodies. Immunohematology 2018;34:11–5. Nance S. A review of the in vitro methods to predict the clinical significance of red cell alloantibodies . Immunohematology 2018 ; 34 : 11 – 5 . Search in Google Scholar

34. Maurer J, Nance S, Nickle P. Relationship of antibody reactivity strength to reactivity in the monocyte monolayer assay (MMA). Transfusion 2018;58:187A. Maurer J Nance S Nickle P. Relationship of antibody reactivity strength to reactivity in the monocyte monolayer assay (MMA) . Transfusion 2018 ; 58 : 187A . Search in Google Scholar

35. Maurer J, Nance S, Nickle P. Monocyte monolayer assay (MMA) to predict clinical signifcance of alloantibodies: a 22 year review. Transfusion 2018;58:103A. Maurer J Nance S Nickle P. Monocyte monolayer assay (MMA) to predict clinical significance of alloantibodies: a 22 year review . Transfusion 2018 ; 58 : 103A . Search in Google Scholar

36. Flickinger C. In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology 2006;22:136–42. Flickinger C. In search of red blood cells for alloimmunized patients with sickle cell disease . Immunohematology 2006 ; 22 : 136 – 42 . Search in Google Scholar

37. Nance S, Scharberg EA, Thornton N, Yahalom V, Lomas-Francis C. International rare donor panels: a review. Vox Sang 2016;110:209–18. Nance S Scharberg EA Thornton N Yahalom V Lomas-Francis C. International rare donor panels: a review . Vox Sang 2016 ; 110 : 209 – 18 . Search in Google Scholar

38. Seltsam A, Wagner FF, Salama A, et al. Antibodies to high frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003;43:1563–6. Seltsam A Wagner FF Salama A Antibodies to high frequency antigens may decrease the quality of transfusion support: an observational study . Transfusion 2003 ; 43 : 1563 – 6 . Search in Google Scholar

39. Branch DR, Gallagher MT, Mison AP, Sy Siok Hian AL, Petz LD. In vitro determination of red cell alloantibody signifcance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984;56:19–29. Branch DR Gallagher MT Mison AP Sy Siok Hian AL Petz LD. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes . Br J Haematol 1984 ; 56 : 19 – 29 . Search in Google Scholar

40. Branch DR, Gallagher MT. Correlation of in vivo alloantibody signifcance or insignifcance with an in vitro monocyte-macrophage phagocytosis assay. Br J Haematol 1986;62: 783–5. Branch DR Gallagher MT. Correlation of in vivo alloantibody significance or insignificance with an in vitro monocyte- macrophage phagocytosis assay . Br J Haematol 1986 ; 62 : 783 – 5 . Search in Google Scholar

41. Branch DR, Gallagher MT. Red blood cell mononuclear phagocyte assay. Vox Sang 1985;48:323–4. Branch DR Gallagher MT. Red blood cell mononuclear phagocyte assay . Vox Sang 1985 ; 48 : 323 – 4 . Search in Google Scholar

42. Branch DR, Gallagher MT. The importance of CO₂ in short-term monocyte-macrophage assays. Transfusion 1985;25: 399–400. Branch DR Gallagher MT. The importance of CO2 in short-term monocyte-macrophage assays . Transfusion 1985 ; 25 : 399 – 400 . Search in Google Scholar

43. Tong TK, Cen S, Branch DR. The monocyte monolayer assay: past, present and future. Transfus Med Rev 2019;33:24–8. Tong TK Cen S Branch DR The monocyte monolayer assay: past, present and future . Transfus Med Rev 2019 ; 33 : 24 – 8 . Search in Google Scholar

44. Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, et al. Evaluation of the functional properties of cryopreserved bufy coat–derived monocytes for monocyte monolayer assay. Transfusion 2018;58:2027–35. Kipkeu BJ Shyian ML da Silveira Cavalcante L Evaluation of the functional properties of cryopreserved buffy coat–derived monocytes for monocyte monolayer assay . Transfusion 2018 ; 58 : 2027 – 35 . Search in Google Scholar

45. Brojer E, Zupanska B, Michalewaks B. Adherence to human monocytes of red cells from autoimmune haemolytic anaemia and red cells sensitized with alloantibodies. Haematologia (Budap) 1982;15:135–45. Brojer E Zupanska B Michalewaks B Adherence to human monocytes of red cells from autoimmune haemolytic anaemia and red cells sensitized with alloantibodies . Haematologia ( Budap ) 1982 ; 15 : 135 – 45 . Search in Google Scholar

46. Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101. Zupańska B Thompson E Brojer E Merry AH Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies . Vox Sang 1987 ; 53 : 96 – 101 . Search in Google Scholar

47. Zupanska B, Brojer E, Richards Y, Lenkiewicz B, Seyfried H, Howell P. Serological and Immunological characteristics of maternal anti-Rh(D) antibodies in predicting severity of haemolytic disease of the newborn. Vox Sang 1989;56:247–53. Zupanska B Brojer E Richards Y Lenkiewicz B Seyfried H Howell P Serological and Immunological characteristics of maternal anti-Rh(D) antibodies in predicting severity of haemolytic disease of the newborn . Vox Sang 1989 ; 56 : 247 – 53 . Search in Google Scholar

48. Zupanska B, Brojer E, McIntosh J, Seyfried H, Howell P. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D. Vox Sang 1990;58:276–80. Zupanska B Brojer E McIntosh J Seyfried H Howell P Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D . Vox Sang 1990 ; 58 : 276 – 80 . Search in Google Scholar

49. Zupanska B, Gronkowska A, Zimeski M. Comparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay. Vox Sang 1995;68:241–2. Zupanska B Gronkowska A Zimeski M Comparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay . Vox Sang 1995 ; 68 : 241 – 2 . Search in Google Scholar

50. Zupanska B. Assays to predict the clinical signifcance of blood group antibodies. Curr Opin Hematol 1998;5:412–6. Zupanska B Assays to predict the clinical significance of blood group antibodies . Curr Opin Hematol 1998 ; 5 : 412 – 6 . Search in Google Scholar

51. Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term ⁵¹Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8. Baldwin ML Ness PM Barrasso C In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units . Transfusion 1985 ; 25 : 34 – 8 . Search in Google Scholar

52. Wren MR, Issitt PD. The monocyte monolayer assay and in vivo antibody activity (abstract). Transfusion 1986;26:548. Wren MR Issitt PD The monocyte monolayer assay and in vivo antibody activity (abstract) . Transfusion 1986 ; 26 : 548 . Search in Google Scholar

53. Issitt PD, Gutgsell NS, Hervis L. Some stored antibodies give unreliable results in the monocyte monolayer assay. Transfusion 1988;28:399–400. Issitt PD Gutgsell NS Hervis L Some stored antibodies give unreliable results in the monocyte monolayer assay . Transfusion 1988 ; 28 : 399 – 400 . Search in Google Scholar

54. Gutgsell NS, Issitt LA, Issitt PD. Transfusion of antigen-positive, serologically-incompatible blood in immunized patients, based solely on the results of a monocyte monolayer assay (MMA) (abstract). Transfusion 1988;28:32S. Gutgsell NS Issitt LA Issitt PD Transfusion of antigen- positive, serologically-incompatible blood in immunized patients, based solely on the results of a monocyte monolayer assay (MMA) (abstract) . Transfusion 1988 ; 28 : 32S . Search in Google Scholar

55. Fabron A Jr, Baleotti W Jr, de Mello AB, et al. Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients. Transfus Apher Sci 2004;31:29–35. Fabron A Jr Baleotti W Jr de Mello AB Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients . Transfus Apher Sci 2004 ; 31 : 29 – 35 . Search in Google Scholar

56. Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100. Noumsi GT Billingsley KL Moulds JM Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay . Transfus Med 2015 ; 25 : 92 – 100 . Search in Google Scholar

57. El-sayed HAN, Abdollah MRA, Raafat SN, Ragab D. Monocyte monolayer assay in pre-transfusion testing: a magic key in transfusing patients with recurrent bad cross-match due to alloimmunization. J Immunol Methods 2021;492:112968. El-sayed HAN Abdollah MRA Raafat SN Ragab D Monocyte monolayer assay in pre-transfusion testing: a magic key in transfusing patients with recurrent bad cross-match due to alloimmunization . J Immunol Methods 2021 ; 492 : 112968 . Search in Google Scholar

58. Bromilow IM, Duguid JK. Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn (letter). Br J Haematol 1991;78:588. Bromilow IM Duguid JK Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn (letter) . Br J Haematol 1991 ; 78 : 588 . Search in Google Scholar

59. Brown SJ, Perkins JT, Sosler SD, Hesketh D, Moise KJ. The monocyte-monolayer assay does not predict severity of hemolytic disease of the newborn (abstract). Transfusion 1991;31(Suppl):53S. Brown SJ Perkins JT Sosler SD Hesketh D Moise KJ The monocyte-monolayer assay does not predict severity of hemolytic disease of the newborn (abstract) . Transfusion 1991 ; 31 ( Suppl ): 53S . Search in Google Scholar

60. Balola AHA, Mayer B, Bartolmäs T, Salama A. A fuorometric erythrophagocytosis assay using diferentiated monocytic THP-1 cells to assess the clinical signifcance of antibodies to red blood cells. Vox Sang 2021;116:1106–16. Balola AHA Mayer B Bartolmäs T Salama A A fluorometric erythrophagocytosis assay using differentiated monocytic THP-1 cells to assess the clinical significance of antibodies to red blood cells . Vox Sang 2021 ; 116 : 1106 – 16 . Search in Google Scholar

61. Nance S, Scandone P, Fassl L, et al. Monocyte monolayer assay (MMA) results are afected by transfusion of incompatible red cells (abstract). Transfusion 1997;37(Suppl):37S. Nance S Scandone P Fassl L Monocyte monolayer assay (MMA) results are affected by transfusion of incompatible red cells (abstract) . Transfusion 1997 ; 37 ( Suppl ): 37S . Search in Google Scholar

62. Branch DR, Sandhu G, Raos M. Monocyte monolayer predictions of clinical outcome for serologically incompatible red blood cells is all about timing. Transfusion 2021;61: 2516–7. Branch DR Sandhu G Raos M Monocyte monolayer predictions of clinical outcome for serologically incompatible red blood cells is all about timing . Transfusion 2021 ; 61 : 2516 – 7 . Search in Google Scholar

63. Nance S. Optimizing the use of limited rare red cells for hematopoietic cell transplant recipients. Transfusion 2007;47: 75 4 –7. Nance S Optimizing the use of limited rare red cells for hematopoietic cell transplant recipients . Transfusion 2007 ; 47 : 754 – 7 . Search in Google Scholar

64. Garratty G. Advances in red blood cell Immunology 1960 to 2009. Transfusion 2010;50:526–35. Garratty G Advances in red blood cell Immunology 1960 to 2009 . Transfusion 2010 ; 50 : 526 – 35 . Search in Google Scholar

65. Meny G. Review: transfusing incompatible RBCs: clinical aspects. Immunohematology 2004;20:161–6. Meny G Review: transfusing incompatible RBCs: clinical aspects . Immunohematology 2004 ; 20 : 161 – 6 . Search in Google Scholar